{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T19:37:28Z","timestamp":1781552248320,"version":"3.54.5"},"reference-count":33,"publisher":"Walter de Gruyter GmbH","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_hmbci-2016-0057_s_999_w2aab3b8b5b1b7b1aab1c14b1Aa\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is increasing evidence that supports the contribution of vitamin D deficiency in metabolic disturbances among women with polycystic ovarian syndrome (PCOS). The aim of this study was to compare 25-hydroxyvitamin D level and the prevalence of metabolic syndrome in the PCOS and normal women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2016-0057_s_998_w2aab3b8b5b1b7b1aab1c14b2Aa\">\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A case-controlled study was conducted in a teaching hospital over a 6-month duration from June 2015 to January 2016. A total of 90 women, who consisted of 45 women with PCOS (study group) and 45 women without PCOS (control group), were recruited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2016-0057_s_997_w2aab3b8b5b1b7b1aab1c14b3Aa\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The final analysis was of 80 women only and the prevalence of vitamin D deficiency (&lt;20 ng\/mL) was high between both groups, i.e. 93.7% but there was no significant difference (p = 0.874). Nevertheless, the prevalence of metabolic syndrome was significantly higher in the study group as compared to the control group (27.5% vs. 5.0%, p = 0.013). There was no statistically significant correlation between vitamin D level with clinical [age, weight, body mass index (BMI), waist and hip circumference, systolic and diastolic blood pressure (SBP and DPB, respectively)] and metabolic parameters (fasting glucose, triglycerides, cholesterol, high-density lipoprotein and low-density lipoprotein) among women with PCOS. However, height was positively correlated (r = 0.338, p = 0.033) and the contrary waist-hip ratio was negatively correlated with vitamin D level (r = \u22120.605, p = 0.048).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2016-0057_s_996_w2aab3b8b5b1b7b1aab1c14b4Aa\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The prevalence of vitamin D deficiency was high in our study population. Nevertheless, the prevalence of metabolic syndrome was higher among women with PCOS as compared to women without PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/hmbci-2016-0057","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T06:01:00Z","timestamp":1506492060000},"source":"Crossref","is-referenced-by-count":5,"title":["Comparison of 25-hydroxyvitamin D and metabolic parameters between women with and without polycystic ovarian syndrome"],"prefix":"10.1515","volume":"31","author":[{"given":"Beng Kwang","family":"Ng","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology , Universiti Kebangsaan Malaysia Medical Centre , Jalan Yaacob Latiff, Cheras , 56000 Kuala Lumpur , Malaysia , Phone: +603-91455949, Fax: +603-91456672, nbk_9955@yahoo.com"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chui Ling","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology , UKM Medical Centre , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Shan","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology , UKM Medical Centre , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanita","family":"Othman","sequence":"additional","affiliation":[{"name":"Department of Pathology , UKM Medical Centre . Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nor Azlin Mohamed","family":"Ismail","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology , UKM Medical Centre , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2017,6,6]]},"reference":[{"key":"2025121207215236259_j_hmbci-2016-0057_ref_001_w2aab3b8b5b1b7b1ab2b2aAa","doi-asserted-by":"crossref","unstructured":"March WA, Moore VM, Wilson KJ, Philips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544\u201351.","DOI":"10.1093\/humrep\/dep399"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_002_w2aab3b8b5b1b7b1ab2b2b1Aa","doi-asserted-by":"crossref","unstructured":"Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yaralji H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27(10):3067\u201373.","DOI":"10.1093\/humrep\/des232"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_003_w2aab3b8b5b1b7b1ab2b2b2Aa","doi-asserted-by":"crossref","unstructured":"Panidis D, Macut D, Tziomalos K, Papadakis E, Mikhailidis K, Kandaraki EA, et al. Prevalence of metabolic syndrome in women with polycystic ovary syndrome. Clin Endocrinol. 2013;78:586\u201392.","DOI":"10.1111\/cen.12008"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_004_w2aab3b8b5b1b7b1ab2b2b3Aa","unstructured":"Azlina I, Azidah AK, Nik Hazlina NH, Shaiful BI. Prevalence and characteristic of metabolic syndrome among polycystic ovarian syndrome patients in Malaysia. Int J Collab Res Intern Med Publ Health. 2012;4(8):1577."},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_005_w2aab3b8b5b1b7b1ab2b2b4Aa","doi-asserted-by":"crossref","unstructured":"Patra SK, Nasrat H, Goswami B, Jain A. Vitamin D as a predictor of insulin resistance in polycystic ovary syndrome. Diabetes Metab Syndr. 2012;6(3):146\u20139.","DOI":"10.1016\/j.dsx.2012.09.006"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_006_w2aab3b8b5b1b7b1ab2b2b5Aa","doi-asserted-by":"crossref","unstructured":"Li HW, Brereton RE, Anderson RA, Wallace AM, Ho CK. Vitamin D deficient is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism. 2011;60(10):1475\u201381.","DOI":"10.1016\/j.metabol.2011.03.002"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_007_w2aab3b8b5b1b7b1ab2b2b6Aa","unstructured":"Wehr E, Pieber TR, Obermayer-Pietsch B. Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot stud. J Endocrinol Invest. 2011;34(10):757\u201363."},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_008_w2aab3b8b5b1b7b1ab2b2b7Aa","doi-asserted-by":"crossref","unstructured":"Yildizhan R, Kurdouglu M, Adali E, Kolusari A, Yildizhan B, Sahin HG, Kamaci M. Serum 25-hydroxycitamin D concentrations in obese and non-obese women with polycystic ovarian syndrome. Arch Gynecol Obstet. 2009;280(4):559\u201363.","DOI":"10.1007\/s00404-009-0958-7"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_009_w2aab3b8b5b1b7b1ab2b2b8Aa","doi-asserted-by":"crossref","unstructured":"Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber TR, et al. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol. 2009;161(4):575\u201382.","DOI":"10.1530\/EJE-09-0432"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_010_w2aab3b8b5b1b7b1ab2b2b9Aa","unstructured":"Darwish H, DeLuca HF. Vitamin D\u2013regulated gene expression. Crit Rev Eukaryot Gene Expr. 1993;3(2):89\u2013116."},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_011_w2aab3b8b5b1b7b1ab2b2c10Aa","doi-asserted-by":"crossref","unstructured":"Mahmoudi T. Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk. Fertil Steril. 2009;92(4):1381\u20133.","DOI":"10.1016\/j.fertnstert.2009.05.002"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_012_w2aab3b8b5b1b7b1ab2b2c11Aa","doi-asserted-by":"crossref","unstructured":"Wehr E, Trummer O, Giuliani A, Gruber HJ, Pieber TR, Obemayer-Pietsch B. Vitamin D-associated polymorphisma are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol. 2011;164(5):741\u20139.","DOI":"10.1530\/EJE-11-0134"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_013_w2aab3b8b5b1b7b1ab2b2c12Aa","doi-asserted-by":"crossref","unstructured":"Teegarden D, Donkin SS. Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev. 2009;22(1):82\u201392.","DOI":"10.1017\/S0954422409389301"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_014_w2aab3b8b5b1b7b1ab2b2c13Aa","doi-asserted-by":"crossref","unstructured":"Plymate SR, Matej LA, Jones RE, Friedl KL. Inhibition of sex hormone binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 1988;67(3):460\u20134.","DOI":"10.1210\/jcem-67-3-460"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_015_w2aab3b8b5b1b7b1ab2b2c14Aa","doi-asserted-by":"crossref","unstructured":"Colonese F, Lagana AS, Colonese E, Sofo V, Salmeri FM, Granese R, et al. The pleiotropic effects of vitamin D in gynaecological and obstetrical diseases: an overview on a hot topic. Biomed Res Int. 2015;2015:986281.","DOI":"10.1155\/2015\/986281"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_016_w2aab3b8b5b1b7b1ab2b2c15Aa","doi-asserted-by":"crossref","unstructured":"Maki KC, Rubin MR, Wong LG, McManus JF, Jensen CD, Marshall JW, et al. Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. J Clin Lipodol. 2009;3(4):289\u201396.","DOI":"10.1016\/j.jacl.2009.07.003"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_017_w2aab3b8b5b1b7b1ab2b2c16Aa","doi-asserted-by":"crossref","unstructured":"Michos E, Melamed ML. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care. 2008;11(1):7\u201312.","DOI":"10.1097\/MCO.0b013e3282f2f4dd"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_018_w2aab3b8b5b1b7b1ab2b2c17Aa","doi-asserted-by":"crossref","unstructured":"Minambres I, Sanchez-Quesada JL, Sanchez-Hernandez J, Rodriguez J, de Leiva A, Perez A. Vitamin D concentrations in familial combined hyperlipidemia: effect of lipid lowering treatment. Diabetol Metab Syndr. 2014;6(1):7.","DOI":"10.1186\/1758-5996-6-7"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_019_w2aab3b8b5b1b7b1ab2b2c18Aa","doi-asserted-by":"crossref","unstructured":"Shafinaz IS, Moy FM. Vitamin D level and its association with adiposity among multi-ethnic adults in Kuala Lumpur, Malaysia: a cross-sectional study. BMC Publ Health. 2016;16:232.","DOI":"10.1186\/s12889-016-2924-1"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_020_w2aab3b8b5b1b7b1ab2b2c19Aa","doi-asserted-by":"crossref","unstructured":"Selimoglu H, Duran C, Kiyici S, Ersoy C, Guclu M, Ozkaya G, et al. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest. 2010;33(4):234\u20138.","DOI":"10.1007\/BF03345785"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_021_w2aab3b8b5b1b7b1ab2b2c20Aa","doi-asserted-by":"crossref","unstructured":"Firouzabadi R, Aflatoonian A, Modarresi S, Sekhavat L, Mohammad Taheri S. Therapeutic effects of calcium and vitamin D supplementation in women with PCOS. Complement Ther Clin Pract. 2012;18(2):85\u20138.","DOI":"10.1016\/j.ctcp.2012.01.005"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_022_w2aab3b8b5b1b7b1ab2b2c21Aa","doi-asserted-by":"crossref","unstructured":"Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152(5):307\u201314.","DOI":"10.7326\/0003-4819-152-5-201003020-00009"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_023_w2aab3b8b5b1b7b1ab2b2c22Aa","doi-asserted-by":"crossref","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_024_w2aab3b8b5b1b7b1ab2b2c23Aa","unstructured":"The IDF consensus worldwide definition of metabolic syndrome. Guideline for definition of the metabolic syndrome. International Diabetes Federation 2006."},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_025_w2aab3b8b5b1b7b1ab2b2c24Aa","doi-asserted-by":"crossref","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol. 2011;96(7):1911\u201330.","DOI":"10.1210\/jc.2011-0385"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_026_w2aab3b8b5b1b7b1ab2b2c25Aa","doi-asserted-by":"crossref","unstructured":"Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol. 2010;121(1-2):297\u2013300.","DOI":"10.1016\/j.jsbmb.2010.02.021"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_027_w2aab3b8b5b1b7b1ab2b2c26Aa","doi-asserted-by":"crossref","unstructured":"Ganie MA, Marwaha RK, Nisar S, Farooqi KJ, Jan RA, Wani SA, et al. Impact of hypovitaminosis D on clinical, hormonal and insulin sensitivity parameters in normal body mass index polycystic ovary syndrome women. J Obstet Gynaecol. 2016;15:1\u201315.","DOI":"10.3109\/01443615.2015.1103715"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_028_w2aab3b8b5b1b7b1ab2b2c27Aa","doi-asserted-by":"crossref","unstructured":"Guducu N, Gormus U, Kutay SS, Kavak ZN, Dunder I. 25-Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome. Gynecol Endocrinol. 2014;30(8):557\u201360.","DOI":"10.3109\/09513590.2014.910189"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_029_w2aab3b8b5b1b7b1ab2b2c28Aa","doi-asserted-by":"crossref","unstructured":"Mazloomi S, Sharifi F, Hajihosseini R, Kalantari S, Mazloomzadeh S. Association between hypoadiponectinemia and low serum concentrations of calcium and vitamin D in women with polycystic ovary syndrome. ISRN Endocrinol. 2012;2012:949427.","DOI":"10.5402\/2012\/949427"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_030_w2aab3b8b5b1b7b1ab2b2c29Aa","doi-asserted-by":"crossref","unstructured":"He C, Lin Z, Robb SW, Ezeamama AE. Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis. Nutrients. 2015;7(6):4555\u201377.","DOI":"10.3390\/nu7064555"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_031_w2aab3b8b5b1b7b1ab2b2c30Aa","doi-asserted-by":"crossref","unstructured":"Mahmoudi T, Gourabi H, Ashrafi M, Yazdi RS, Ezabadi Z. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Fertil Steril. 2010;93(4):1208\u201314.","DOI":"10.1016\/j.fertnstert.2008.11.031"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_032_w2aab3b8b5b1b7b1ab2b2c31Aa","doi-asserted-by":"crossref","unstructured":"Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5):820\u20135.","DOI":"10.1093\/ajcn\/79.5.820"},{"key":"2025121207215236259_j_hmbci-2016-0057_ref_033_w2aab3b8b5b1b7b1ab2b2c32Aa","doi-asserted-by":"crossref","unstructured":"Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, et al. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Experiment Clin Endocrinol Diab. 2006;114(10):577\u201383.","DOI":"10.1055\/s-2006-948308"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/hmbci.2017.31.issue-3\/hmbci-2016-0057\/hmbci-2016-0057.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2016-0057\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2016-0057\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:15:52Z","timestamp":1765527352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2016-0057\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,6]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,6,6]]},"published-print":{"date-parts":[[2017,9,26]]}},"alternative-id":["10.1515\/hmbci-2016-0057"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2016-0057","relation":{},"ISSN":["1868-1891"],"issn-type":[{"value":"1868-1891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,6]]},"article-number":"20160057"}}